REFERENCES

 

Aderson CC  Cook JL Kreeger JM  Tomlinson JL and Wagner-Mann CC  (1999)

In vitro effects of glucosamine and acetylsalicylate on canine chondrocytes in three-dimensional culture

Am J Vet Res  60  1546-1551

 

Andermann G and Dietz M  (1982)

The influence of the route of administration on the bioavailability of an endogenous macromolecule:  chondroitin sulphate (CSA)

Eur J Drug Metab Pharmacol  7 (1)  11-16

 

Avouac B  (1993)

Slow Acting Drugs in Osteoarthritis:  a step towards disease modification

Rev Esp Reumatol  20 (Suppl 1)  221-222

 

Baici A  Horler D  Moser B et al  (1992)

Analysis of glycosaminoglycans in human serum after oral administration of chondroitin sulphate

Rheumatol Int  12  81-88

 

Bassleer C  Henrotin Y and Franchiment P  (1992)

In vitro evaluation of drugs proposed as chondroprotective agents

Int J Tissue React  14  231-241

 

Bassleer C  Reginster JY and Franchiment P  (1993)

Effects of glucosamine on differentiated human chondrocytes cultivated in clusters

Rev Esp Reumatol  20 (Suppl 1)  96

 

Bourgeois P  Charles G  Dehais J  Delcambue B  Kuntz J-L and Rozenberg S  (1998)

Efficacy and tolerability of chondroitin sulfate 1200mg/day vs chondroitin sulfate 3 x 400 mg/day vs placebo

Osteoarthritis and Cartilage  6  25-30

 

Bucsi L and Poór G  (1998)

Efficacy and tolerability of oral chondroitin sulfate as a symptomatic slow-acting drug for osteoarthritis (SYSADOA) in the treatment of knee osteoarthritis

Osteoarthritis and Cartilage  6  31-36

 

Burkhardt D and Ghosh P  (1987)

Laboratory evaluation of antiarthritic drugs as potential chondroprotective agents

Sem Arth Rheum  17  (2)  Suppl 1  3-34

 

Canapp SO  McLaughlin RM  Hoskinson JJ  Roush JK and Butine MD  (1999)

Scintigraphic evaluation of dogs with acute synovitis after treatment with glucosamine hydrochloride and chondroitin sulfate

Am J Vet Res  60  1552-1557

 

Clark CC  Richards CF and Iozzo RV  (1991)

Post-translational alternations in newly synthesised cartilage proteoglycans induced by the glutamine analogue 6-diazo-5-oxo-L-norleucine

Biochem J  273  283-288

 

Conte A  De Bernardi M  Palmieri L et al  (1991)

Metabolic fate of exogenous chondroitin sulphate in man

Arneimittelforsch/Drug Res  41  768-772

 

Conte A  Volpi N  Palmieri L  Bahous I and Ronca G  (1995)

Biochemical and pharmacokinetic aspects of oral treatment with chondroitin sulphate

Drug Res  45  918-925

 

Crolle G and D’Est E  (1980)

Glucosamine sulphate for the management of arthrosis:  a controlled clinical investigation

Curr Res Med opinion  7 (2)  114-119

 

D’Ambrosio E  Casa B  Bompani R  Scali G and Scali M  (1981)

Glucosamine sulphate:  a controlled clinical investigation in arthrosis

Pharmatherapeutica  2 (8)  504-508

 

Dohlman  CH  (1956)

The fate of the sulfate group of chondroitin sulfate after administration to rats

Acta Physiol Scand  37  220-234

 

Dorna VI and Guerrero RC  (1998)

Effects of oral and intramuscular use of chondroitin sulfate in induced equine aseptic arthritis

J Equine Vet Sci  18  548-555

 

Drovanti A  Bignamini AA and Rovati AL  (1980)

Therapeutic activity of oral glucosamine sulphate in osteoarthritis:  a placebo-controlled double-blind investigation

Clin Ther 3 (4)  260-272

 

Eichler J and Nöh E  (1970)

Therapy of deforming arthrosis through the action upon the cartilagenous metabolism

Orthop Prax  9  225-229

 

Fenton  JI et al  (1999a)

Glucosamine inhibits cartilage degradation in equine articular cartilage explants

J Eq Vet Sci  19  (7)  454

 

Fenton JI  Chelebek-Brown KA  Peters TL and Canon JP  (1999b)

Glucosamine inhibits interleukin -1b and lipopolysaccharide-induced cartilage degradation in vitro

Vet Surg  28  388

 

Ghosh P  Wells C  Smith M and Hutadilok N  (1990)

Chondroprotection, myth or reality:  an experimental approach

Sem Arthritis Rheum  19  3-9

 

Giocovelli G and Rovati LC  (1993)

Clinical efficacy of glucosamine sulfate in osteoarthritis of the spine

Rev Esp Reumatol  20 (Suppl 1)  96

 

Hanson RR  Smalley LR  Huff GK  White S and Hammad TA  (1997)

Oral treatment with a glucosamine-chondroitin sulfate compound for degenerative joint disease in horses:  25 cases

Equine Practice  19 16-22

 

Humphrey D  (1999)

Personal communication

 

Karzel K and Domenjoz R  (1971)

Effects of hexosamine derivatives and uronic acid derivatives on glycosaminoglycan metabolism of fibroblast cultures

Pharmacology  5  337-345

 

Kim JA and Conrad HE  (1974)

Effect of D-glucosamine concentration on the kinetics of mucopolysaccharide biosynethesis in cultured chick embryo vertebral cartilage

J Biol Chem  249  3091-3097

 

Konador A and Kawiak J  (1977)

Changes in chondroitin sulfate concentration in rabbit blood plasma depending on the method of its administration

Arch Immunol Ther Exp (Warsz)  25  895-903

 

Latino D  (1999)

Personal communication

 

Lequesne M  (1993)

Guidelines for testing slow acting drugs in osteoarthritis (SADOAs)

Rev Esp Rheumatol  20 (Suppl 1) 220-221

 

Lequesne M  Brandt K  Bellamy N  Moskowitz R  Menkes CJ  Pelletier JP  Altman R (1994)

Guidelines for testing Slow Acting Drugs in Osteoarthritis

J Rheumatol  20 (Suppl) 65-73

 

Lualdi P  (1993)

Bioavailability of oral chondroitin sulfate

Rheumatol Int  13  39-40

 

Morveale P  Manopulo R  Galati M  Boccarera L  Saponati G and Bocchi L  (1996)

Comparison of the anti-inflammatory efficacy of chondroitin sulphate and diclofenac sodium in patients with knee osteoarthritis

J Rheumatol  23  1385-1391

 

Müller-Fassbender H  Bach GL  Haase W  Rovati LC and Setnikar I  (1994)

Glucosamine sulfate compared to ibuprofen in osteoarthritis of the knee

Osteoarthritis and Cartilage  2  61-69

 

Mund-Hoyn W-D  (1980)

Medical treatment of spinal arthrosis with glucosamine or phenylbutazone.  A controlled study.

Therapiewoche  30  5922-5928

 

Murnane TW and Belt WD  (1972)

Uptake of tritiated glucosamine by femur and mandible of 7-day old and adult mice

J Dent Res  51  652-656

 

Németh-Csóka M  Kajtár M and Kajtár J  (1977)

The role of sulphation of glycosaminoglycans in their structural and functional characteristics

Connect Tissue Res  5  1-6

 

Noack W  Fischer M  Förster KK  Rovati LC and Setnikar I  (1994)

Glucosamine sulfate in osteoarthritis of the knee

Osteoarthritis Cart  2  51-59

 

Palmieri L  Conte A  Giovannini L  Lualdi P and Ronca G  (1990)

Metabolic fate of exogenous chondroitin sulfate in the experimental animal

Arzeim Forsch/Drug Res  40  319-323

 

Paroli E  Antonilli L and Biffoni M  (1991)

A pharmacological approach to glycosaminoglycans

Drugs Exp Clin Res 17  9-19

 

Pujalte JM  Llavore EP and Ylescupidez FR  (1980)

Double-blind clinical evaluation of oral glucosamine sulphate in the basic treatment of osteoarthritis

Curr Res Med Opinion  7 (2)  110-114

 

Raiss R  (1985)

Influence of glucosamine sulfate on experimentally impaired articular cartilage:  test of ultrastructural changes in chondrocytes using morphometry

Fortschr Med  103  658-662

 

Reichelt A  Fuorster KK  Fischer M  Rovati LC and Setnikar I  (1994)

Efficacy and safety of intramuscular glucosamine sulphate in osteoarthritis of the knee

Arneim-Forsch/Drug Research  44  74-80

 

Rodén L  (1956)

Effect of hexosamines on the synthesis of chondroitin sulphuric acid in vitro

Arkh Kemi  10  345-352

 

Ronca G and Conte A  (1993)

Metabolic fate of partially depolymerised shark chondroitin sulfate in man

Int J Clin Pharm Res  13  27-34

 

Ronca F  Palmieri L  Panicucci P and Ronca G  (1998)

Anti-inflammatory activity of chondroitin sulphate

Osteoarthritis and Cartilage  6 (Suppl A)  14-21

 


 

Rovati LC  Setnikar I  Förster KK  REichlert A and Noack W  (1993)

Glucosamine sulfate in gonarthrosis:  efficacy in placebo controlled studies

Rev Esp Reumatol  20 (Suppl 1)  72

 

Salyers AA (1979)

Energy sources of major intestinal fermentative anaerobes

Am J Clin Nutr  32  158-163

 

Salyers AA and O’Brien M  (1980)

Cellular location of enzymes involved in chondroitin sulfate breakdown by Bacteroides thelaiotaomicron

J Bacteriol  143  772-780

 

Serni V  (1993)

Profile of glucosamine sulfate as an example of Slow Acting Drug in Osteoarthritis

Rev Esp Reumatol  20 (Suppl 1)  222

 

Setnikar I  Cereda R  Pacini MA and Revel L  (1991a)

Antireactive properties of glucosamine sulphate

Arzneim-Forsch/Drug Res  41  157-161

 

Setnikar I  Giachetti C and Zanolo G  (1984)

Absorption, distribution and excretion of radioactivity after a single intravenous or oral administration of [14C] glucosamine to the rat

Pharmacotherapeutica  3  538-550

 

Setnikar I  Giachetti C and Zanolo G  (1986)

Pharmacokinetics of glucosamine in the dog and man

Arzneim Forsch/Drug Res  36 729-735

 

Setnikar I  Pacini MA and Revel L  (1991b)

Antiarthritic effects of glucosamine sulphate studies on animal models

Arzneim-Forsch/Drug Res  542-545

 

Setnikar I  Palumbo R  Canali S and Zonolo G  (1993)

Pharmacokinetics of glucosamine in man

Arzneim Forsch/Drug Res  43  1109-1113

 

Tapadinhas MJ  Rivera IC and Bignamini AA  (1982)

Oral glucosamine sulphate in the management of arthrosis:  report on a multicentre open investigation in Portugal

Pharmatherapeutica  3 (3)  157-168

 

Tesoriere G  Dores F  Magistro D et al  (1972)

Intestinal absorption of glucosamine and N-acetylglucosamine

Experertia  28  770-771

 

Todhunter  RJ  (1996) 

Anatomy and physiology of synovial joints

In Joint Disease in the Horse

Eds:  C W McIlwraith and G W Trotter

W B Saunders  Philaldephia  pp 1-28

 

Trotter GW  (1996)

Polysulfated glycosaminoglycan (Adequan)

In Joint Disease in the Horse

Eds:  C Wayne McIlwraith and Gayle W Trotter

WB Saunders Co  Philadelphia  pp 270-280

 

Uebelhart D  Thonar EJ-MA  Delmas PD  Chantraine A and Vignon E  (1998a)

Effects of oral chondroitin sulfate on the progression of knee osteoarthritis:  a pilot study

Osteoarthritis and Cartilage  6 (Suppl A)  39-46

 

Uebelhart D  Thonar EJ-MA  Zhang J and Williams JM  (1998b)

Protective effect of exogenous chondroitin 4, 6-sulfate in the acute degradation of articular cartilage in the rabbit

Osteoarthritis and Cartilage  6 (Suppl A)  6-13

 

Vajardul Y  (1981)

Double-blind clinical evaluation of intra-articular glucosamine in outpatients with gonarthrosis

Clin Ther  3 (5)  336-343

 

Vaz AL  (1982)

Double-blind clinical evaluation of the relative efficacy of ibuprofen and glucosamine sulphate in the management of osteoarthrosis of the knee in outpatients

Curr Med Res Opinion  8 (3)  145-149

 

Vetter von G  (1969)

Lokale therapie der arthrosen mit glukosaminen  (Dona 200)

Munch Med Wochenschr  III  1499-1502

 

Vidal y Plana RR  Bizzarri D and Rovati AL (1978)

Articular cartilage pharmacology.  In vitro studies on glucosamine and nonsteroidal anti-inflammatory drugs

Pharmacol Res Comm  10  557-569

 

Vidal y Plana RR and Karzel K  (1980)

Glucosamine:  its role in the articular cartilage metabolism 2.  Studies on rat and human articular cartilage

Fortschr Med  98  801-806

 

White GW  Wynn Jones E  Hamm J and Sanders T (1994)

The efficacy of orally administered sulfated glycosaminoglycan in chemically induced equine synovitis and degenerative joint disease

J Equine vet Sci  14  350-353

 

Yamanashi S  Toyoda H  Furuya N  Harada T  Yoshida K  Toida T and Imanari T       

(1991)

Metabolic study on chondroitin sulfate in rabbits

Yakagaku Zasshi  III  73-76